Source: Research Seminar 2007 - Severe Asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Joos (Ghent, Belgium). Inflammatory Pathways and Mediators in the Pathogenesis of Severe Asthma. Research Seminar 2007 - Severe Asthma

Member's Comments

No comment yet.

Related content which might interest you: Comprehensive Metabolic Profiling Reveals Metabolic Perturbances and Identifies Potential Biomarkers in Chronic Persistent Bronchial Asthma with Different Levels of Eosinophilia Percentage Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 How to Manage Severe Asthma, the Value of Inflammation Monitoring Source: Research Seminar 2007 - Severe Asthma Year: 2007 Dupilumab Effect on Lung Function in Patients With Uncontrolled, Moderate-to-Severe Asthma With an Allergic Phenotype Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Epidemiology and Triggers of Severe Asthma Source: Research Seminar 2007 - Severe Asthma Year: 2007 Aerobic Exercise Improves Asthma Phenotype in a Model of Severe Asthma: Involvement of Kinins Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease Year: 2021 1-?-alkyl-glycerols Reduce Level of Inflammatory Cytokines In Obese Asthma Source: Virtual Congress 2021 – Pharmacology of airway diseases: clinical and laboratory studies Year: 2021 Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Aerobic Training Improves Pulmonary and Systemic Inflammatory and Fibrotic Response in Asthmatics Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases Year: 2021 Applying Modern Molecular Microbiological Techniques to Identify Treatable Chronic Bacterial Airway Infection in Severe Asthma Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020 Creatine Supplementation Augments Chronic Allergic Airway Inflammation and Remodelling: from Mice to Human Evidence Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium Year: 2018 Effect of Antifibrotic Therapies in Patients with Interstitial Pneumonia with Autoimmune Features Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment Year: 2020 Low Level of  Airway Mucin 2 Predict Severe Exacerbations in Patients with Severe Chronic Obstructive Pulmonary Disease Source: International Congress 2017 – COPD biomarkers Year: 2017 mTOR Pathway Activation Drives Lung-Cell Senescence and Emphysema in Chronic Obstructive Pulmonary Disease Source: International Congress 2017 – Translational studies of lung disease Year: 2017 Managing T2-High Inflammation in Severe Asthma - Are Biomarkers Better Than Clinician Judgement? Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020 Co-Morbidities Are Serious Confounders of Asthma in Severe Asthma Source: Research Seminar 2007 - Severe Asthma Year: 2007 Exploration of the Genetic Etiology of Complex Inflammatory Disorders: The Example of Crohn’s Disease Source: Research Seminar 2004 - Genotyping and Phenotyping of Diffuse Parenchymal Lung Diseases Year: 2004 The Relationship Between Symptoms, Exacerbations And Treatment Response in Bronchiectasis Source: Virtual Congress 2020 – Bronchiectasis: epidemiology, endotyping and therapy Year: 2020 Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Does a Tailored Intervention to Promote Adherence in Patients with Chronic Lung Disease Affect Exacerbations? Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Mechanisms of FeNO Non-Suppression in Severe Asthma: Analysis of Sputum Type 2 Cytokines and Chemokines Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020